Global Liposome Assisted Drug Delivery Market Size, Status and Forecast 2020-2026
![](/report_cover/6975/global-liposome-assisted-drug-delivery-market-size-status-n-forecast-2020-2026_en.gif)
Liposome Assisted Drug Delivery market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Liposome Assisted Drug Delivery market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
The key players covered in this study
- Gilead Sciences
- Pacira
- Sun Pharmaceutical
- Johnson & Johnson
- Luye Pharma
- Sigma-Tau Group
- Ipsen (Onivyde)
- CSPC
- Teva Pharmaceutical
- Novartis
- Fudan-Zhangjiang
- Liposomal Doxorubicin
- Liposomal Amphoteracin B
- Liposomal Paclitaxel
- Others
- Fungal Infection Therapy
- Cancer & Tumor Therapy
- Others
- North America
- Europe
- China
- Japan
- Southeast Asia
- India
- Central & South America
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Liposome Assisted Drug Delivery Revenue
1.4 Market by Type
1.4.1 Global Liposome Assisted Drug Delivery Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Liposomal Doxorubicin
1.4.3 Liposomal Amphoteracin B
1.4.4 Liposomal Paclitaxel
1.4.5 Others
1.5 Market by Application
1.5.1 Global Liposome Assisted Drug Delivery Market Share by Application: 2020 VS 2026
1.5.2 Fungal Infection Therapy
1.5.3 Cancer & Tumor Therapy
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Liposome Assisted Drug Delivery Market Perspective (2015-2026)
2.2 Global Liposome Assisted Drug Delivery Growth Trends by Regions
2.2.1 Liposome Assisted Drug Delivery Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Liposome Assisted Drug Delivery Historic Market Share by Regions (2015-2020)
2.2.3 Liposome Assisted Drug Delivery Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Liposome Assisted Drug Delivery Market Growth Strategy
2.3.6 Primary Interviews with Key Liposome Assisted Drug Delivery Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Liposome Assisted Drug Delivery Players by Market Size
3.1.1 Global Top Liposome Assisted Drug Delivery Players by Revenue (2015-2020)
3.1.2 Global Liposome Assisted Drug Delivery Revenue Market Share by Players (2015-2020)
3.1.3 Global Liposome Assisted Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Liposome Assisted Drug Delivery Market Concentration Ratio
3.2.1 Global Liposome Assisted Drug Delivery Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Liposome Assisted Drug Delivery Revenue in 2019
3.3 Liposome Assisted Drug Delivery Key Players Head office and Area Served
3.4 Key Players Liposome Assisted Drug Delivery Product Solution and Service
3.5 Date of Enter into Liposome Assisted Drug Delivery Market
3.6 Mergers & Acquisitions, Expansion Plans
4 MARKET SIZE BY TYPE (2015-2026)
4.1 Global Liposome Assisted Drug Delivery Historic Market Size by Type (2015-2020)
4.2 Global Liposome Assisted Drug Delivery Forecasted Market Size by Type (2021-2026)
5 MARKET SIZE BY APPLICATION (2015-2026)
5.1 Global Liposome Assisted Drug Delivery Market Size by Application (2015-2020)
5.2 Global Liposome Assisted Drug Delivery Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Liposome Assisted Drug Delivery Market Size (2015-2020)
6.2 Liposome Assisted Drug Delivery Key Players in North America (2019-2020)
6.3 North America Liposome Assisted Drug Delivery Market Size by Type (2015-2020)
6.4 North America Liposome Assisted Drug Delivery Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Liposome Assisted Drug Delivery Market Size (2015-2020)
7.2 Liposome Assisted Drug Delivery Key Players in Europe (2019-2020)
7.3 Europe Liposome Assisted Drug Delivery Market Size by Type (2015-2020)
7.4 Europe Liposome Assisted Drug Delivery Market Size by Application (2015-2020)
8 CHINA
8.1 China Liposome Assisted Drug Delivery Market Size (2015-2020)
8.2 Liposome Assisted Drug Delivery Key Players in China (2019-2020)
8.3 China Liposome Assisted Drug Delivery Market Size by Type (2015-2020)
8.4 China Liposome Assisted Drug Delivery Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Liposome Assisted Drug Delivery Market Size (2015-2020)
9.2 Liposome Assisted Drug Delivery Key Players in Japan (2019-2020)
9.3 Japan Liposome Assisted Drug Delivery Market Size by Type (2015-2020)
9.4 Japan Liposome Assisted Drug Delivery Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Liposome Assisted Drug Delivery Market Size (2015-2020)
10.2 Liposome Assisted Drug Delivery Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Liposome Assisted Drug Delivery Market Size by Type (2015-2020)
10.4 Southeast Asia Liposome Assisted Drug Delivery Market Size by Application (2015-2020)
11 INDIA
11.1 India Liposome Assisted Drug Delivery Market Size (2015-2020)
11.2 Liposome Assisted Drug Delivery Key Players in India (2019-2020)
11.3 India Liposome Assisted Drug Delivery Market Size by Type (2015-2020)
11.4 India Liposome Assisted Drug Delivery Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Liposome Assisted Drug Delivery Market Size (2015-2020)
12.2 Liposome Assisted Drug Delivery Key Players in Central & South America (2019-2020)
12.3 Central & South America Liposome Assisted Drug Delivery Market Size by Type (2015-2020)
12.4 Central & South America Liposome Assisted Drug Delivery Market Size by Application (2015-2020)
13KEY PLAYERS PROFILES
13.1 Gilead Sciences
13.1.1 Gilead Sciences Company Details
13.1.2 Gilead Sciences Business Overview
13.1.3 Gilead Sciences Liposome Assisted Drug Delivery Introduction
13.1.4 Gilead Sciences Revenue in Liposome Assisted Drug Delivery Business (2015-2020))
13.1.5 Gilead Sciences Recent Development
13.2 Pacira
13.2.1 Pacira Company Details
13.2.2 Pacira Business Overview
13.2.3 Pacira Liposome Assisted Drug Delivery Introduction
13.2.4 Pacira Revenue in Liposome Assisted Drug Delivery Business (2015-2020)
13.2.5 Pacira Recent Development
13.3 Sun Pharmaceutical
13.3.1 Sun Pharmaceutical Company Details
13.3.2 Sun Pharmaceutical Business Overview
13.3.3 Sun Pharmaceutical Liposome Assisted Drug Delivery Introduction
13.3.4 Sun Pharmaceutical Revenue in Liposome Assisted Drug Delivery Business (2015-2020)
13.3.5 Sun Pharmaceutical Recent Development
13.4 Johnson & Johnson
13.4.1 Johnson & Johnson Company Details
13.4.2 Johnson & Johnson Business Overview
13.4.3 Johnson & Johnson Liposome Assisted Drug Delivery Introduction
13.4.4 Johnson & Johnson Revenue in Liposome Assisted Drug Delivery Business (2015-2020)
13.4.5 Johnson & Johnson Recent Development
13.5 Luye Pharma
13.5.1 Luye Pharma Company Details
13.5.2 Luye Pharma Business Overview
13.5.3 Luye Pharma Liposome Assisted Drug Delivery Introduction
13.5.4 Luye Pharma Revenue in Liposome Assisted Drug Delivery Business (2015-2020)
13.5.5 Luye Pharma Recent Development
13.6 Sigma-Tau Group
13.6.1 Sigma-Tau Group Company Details
13.6.2 Sigma-Tau Group Business Overview
13.6.3 Sigma-Tau Group Liposome Assisted Drug Delivery Introduction
13.6.4 Sigma-Tau Group Revenue in Liposome Assisted Drug Delivery Business (2015-2020)
13.6.5 Sigma-Tau Group Recent Development
13.7 Ipsen (Onivyde)
13.7.1 Ipsen (Onivyde) Company Details
13.7.2 Ipsen (Onivyde) Business Overview
13.7.3 Ipsen (Onivyde) Liposome Assisted Drug Delivery Introduction
13.7.4 Ipsen (Onivyde) Revenue in Liposome Assisted Drug Delivery Business (2015-2020)
13.7.5 Ipsen (Onivyde) Recent Development
13.8 CSPC
13.8.1 CSPC Company Details
13.8.2 CSPC Business Overview
13.8.3 CSPC Liposome Assisted Drug Delivery Introduction
13.8.4 CSPC Revenue in Liposome Assisted Drug Delivery Business (2015-2020)
13.8.5 CSPC Recent Development
13.9 Teva Pharmaceutical
13.9.1 Teva Pharmaceutical Company Details
13.9.2 Teva Pharmaceutical Business Overview
13.9.3 Teva Pharmaceutical Liposome Assisted Drug Delivery Introduction
13.9.4 Teva Pharmaceutical Revenue in Liposome Assisted Drug Delivery Business (2015-2020)
13.9.5 Teva Pharmaceutical Recent Development
13.10 Novartis
13.10.1 Novartis Company Details
13.10.2 Novartis Business Overview
13.10.3 Novartis Liposome Assisted Drug Delivery Introduction
13.10.4 Novartis Revenue in Liposome Assisted Drug Delivery Business (2015-2020)
13.10.5 Novartis Recent Development
13.11 Fudan-Zhangjiang
10.11.1 Fudan-Zhangjiang Company Details
10.11.2 Fudan-Zhangjiang Business Overview
10.11.3 Fudan-Zhangjiang Liposome Assisted Drug Delivery Introduction
10.11.4 Fudan-Zhangjiang Revenue in Liposome Assisted Drug Delivery Business (2015-2020)
10.11.5 Fudan-Zhangjiang Recent Development
14ANALYST'S VIEWPOINTS/CONCLUSIONS
15APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Liposome Assisted Drug Delivery Revenue
1.4 Market by Type
1.4.1 Global Liposome Assisted Drug Delivery Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Liposomal Doxorubicin
1.4.3 Liposomal Amphoteracin B
1.4.4 Liposomal Paclitaxel
1.4.5 Others
1.5 Market by Application
1.5.1 Global Liposome Assisted Drug Delivery Market Share by Application: 2020 VS 2026
1.5.2 Fungal Infection Therapy
1.5.3 Cancer & Tumor Therapy
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Liposome Assisted Drug Delivery Market Perspective (2015-2026)
2.2 Global Liposome Assisted Drug Delivery Growth Trends by Regions
2.2.1 Liposome Assisted Drug Delivery Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Liposome Assisted Drug Delivery Historic Market Share by Regions (2015-2020)
2.2.3 Liposome Assisted Drug Delivery Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Liposome Assisted Drug Delivery Market Growth Strategy
2.3.6 Primary Interviews with Key Liposome Assisted Drug Delivery Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Liposome Assisted Drug Delivery Players by Market Size
3.1.1 Global Top Liposome Assisted Drug Delivery Players by Revenue (2015-2020)
3.1.2 Global Liposome Assisted Drug Delivery Revenue Market Share by Players (2015-2020)
3.1.3 Global Liposome Assisted Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Liposome Assisted Drug Delivery Market Concentration Ratio
3.2.1 Global Liposome Assisted Drug Delivery Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Liposome Assisted Drug Delivery Revenue in 2019
3.3 Liposome Assisted Drug Delivery Key Players Head office and Area Served
3.4 Key Players Liposome Assisted Drug Delivery Product Solution and Service
3.5 Date of Enter into Liposome Assisted Drug Delivery Market
3.6 Mergers & Acquisitions, Expansion Plans
4 MARKET SIZE BY TYPE (2015-2026)
4.1 Global Liposome Assisted Drug Delivery Historic Market Size by Type (2015-2020)
4.2 Global Liposome Assisted Drug Delivery Forecasted Market Size by Type (2021-2026)
5 MARKET SIZE BY APPLICATION (2015-2026)
5.1 Global Liposome Assisted Drug Delivery Market Size by Application (2015-2020)
5.2 Global Liposome Assisted Drug Delivery Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Liposome Assisted Drug Delivery Market Size (2015-2020)
6.2 Liposome Assisted Drug Delivery Key Players in North America (2019-2020)
6.3 North America Liposome Assisted Drug Delivery Market Size by Type (2015-2020)
6.4 North America Liposome Assisted Drug Delivery Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Liposome Assisted Drug Delivery Market Size (2015-2020)
7.2 Liposome Assisted Drug Delivery Key Players in Europe (2019-2020)
7.3 Europe Liposome Assisted Drug Delivery Market Size by Type (2015-2020)
7.4 Europe Liposome Assisted Drug Delivery Market Size by Application (2015-2020)
8 CHINA
8.1 China Liposome Assisted Drug Delivery Market Size (2015-2020)
8.2 Liposome Assisted Drug Delivery Key Players in China (2019-2020)
8.3 China Liposome Assisted Drug Delivery Market Size by Type (2015-2020)
8.4 China Liposome Assisted Drug Delivery Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Liposome Assisted Drug Delivery Market Size (2015-2020)
9.2 Liposome Assisted Drug Delivery Key Players in Japan (2019-2020)
9.3 Japan Liposome Assisted Drug Delivery Market Size by Type (2015-2020)
9.4 Japan Liposome Assisted Drug Delivery Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Liposome Assisted Drug Delivery Market Size (2015-2020)
10.2 Liposome Assisted Drug Delivery Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Liposome Assisted Drug Delivery Market Size by Type (2015-2020)
10.4 Southeast Asia Liposome Assisted Drug Delivery Market Size by Application (2015-2020)
11 INDIA
11.1 India Liposome Assisted Drug Delivery Market Size (2015-2020)
11.2 Liposome Assisted Drug Delivery Key Players in India (2019-2020)
11.3 India Liposome Assisted Drug Delivery Market Size by Type (2015-2020)
11.4 India Liposome Assisted Drug Delivery Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Liposome Assisted Drug Delivery Market Size (2015-2020)
12.2 Liposome Assisted Drug Delivery Key Players in Central & South America (2019-2020)
12.3 Central & South America Liposome Assisted Drug Delivery Market Size by Type (2015-2020)
12.4 Central & South America Liposome Assisted Drug Delivery Market Size by Application (2015-2020)
13KEY PLAYERS PROFILES
13.1 Gilead Sciences
13.1.1 Gilead Sciences Company Details
13.1.2 Gilead Sciences Business Overview
13.1.3 Gilead Sciences Liposome Assisted Drug Delivery Introduction
13.1.4 Gilead Sciences Revenue in Liposome Assisted Drug Delivery Business (2015-2020))
13.1.5 Gilead Sciences Recent Development
13.2 Pacira
13.2.1 Pacira Company Details
13.2.2 Pacira Business Overview
13.2.3 Pacira Liposome Assisted Drug Delivery Introduction
13.2.4 Pacira Revenue in Liposome Assisted Drug Delivery Business (2015-2020)
13.2.5 Pacira Recent Development
13.3 Sun Pharmaceutical
13.3.1 Sun Pharmaceutical Company Details
13.3.2 Sun Pharmaceutical Business Overview
13.3.3 Sun Pharmaceutical Liposome Assisted Drug Delivery Introduction
13.3.4 Sun Pharmaceutical Revenue in Liposome Assisted Drug Delivery Business (2015-2020)
13.3.5 Sun Pharmaceutical Recent Development
13.4 Johnson & Johnson
13.4.1 Johnson & Johnson Company Details
13.4.2 Johnson & Johnson Business Overview
13.4.3 Johnson & Johnson Liposome Assisted Drug Delivery Introduction
13.4.4 Johnson & Johnson Revenue in Liposome Assisted Drug Delivery Business (2015-2020)
13.4.5 Johnson & Johnson Recent Development
13.5 Luye Pharma
13.5.1 Luye Pharma Company Details
13.5.2 Luye Pharma Business Overview
13.5.3 Luye Pharma Liposome Assisted Drug Delivery Introduction
13.5.4 Luye Pharma Revenue in Liposome Assisted Drug Delivery Business (2015-2020)
13.5.5 Luye Pharma Recent Development
13.6 Sigma-Tau Group
13.6.1 Sigma-Tau Group Company Details
13.6.2 Sigma-Tau Group Business Overview
13.6.3 Sigma-Tau Group Liposome Assisted Drug Delivery Introduction
13.6.4 Sigma-Tau Group Revenue in Liposome Assisted Drug Delivery Business (2015-2020)
13.6.5 Sigma-Tau Group Recent Development
13.7 Ipsen (Onivyde)
13.7.1 Ipsen (Onivyde) Company Details
13.7.2 Ipsen (Onivyde) Business Overview
13.7.3 Ipsen (Onivyde) Liposome Assisted Drug Delivery Introduction
13.7.4 Ipsen (Onivyde) Revenue in Liposome Assisted Drug Delivery Business (2015-2020)
13.7.5 Ipsen (Onivyde) Recent Development
13.8 CSPC
13.8.1 CSPC Company Details
13.8.2 CSPC Business Overview
13.8.3 CSPC Liposome Assisted Drug Delivery Introduction
13.8.4 CSPC Revenue in Liposome Assisted Drug Delivery Business (2015-2020)
13.8.5 CSPC Recent Development
13.9 Teva Pharmaceutical
13.9.1 Teva Pharmaceutical Company Details
13.9.2 Teva Pharmaceutical Business Overview
13.9.3 Teva Pharmaceutical Liposome Assisted Drug Delivery Introduction
13.9.4 Teva Pharmaceutical Revenue in Liposome Assisted Drug Delivery Business (2015-2020)
13.9.5 Teva Pharmaceutical Recent Development
13.10 Novartis
13.10.1 Novartis Company Details
13.10.2 Novartis Business Overview
13.10.3 Novartis Liposome Assisted Drug Delivery Introduction
13.10.4 Novartis Revenue in Liposome Assisted Drug Delivery Business (2015-2020)
13.10.5 Novartis Recent Development
13.11 Fudan-Zhangjiang
10.11.1 Fudan-Zhangjiang Company Details
10.11.2 Fudan-Zhangjiang Business Overview
10.11.3 Fudan-Zhangjiang Liposome Assisted Drug Delivery Introduction
10.11.4 Fudan-Zhangjiang Revenue in Liposome Assisted Drug Delivery Business (2015-2020)
10.11.5 Fudan-Zhangjiang Recent Development
14ANALYST'S VIEWPOINTS/CONCLUSIONS
15APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
LIST OF TABLES
Table 1. Liposome Assisted Drug Delivery Key Market Segments
Table 2. Key Players Covered: Ranking by Liposome Assisted Drug Delivery Revenue
Table 3. Ranking of Global Top Liposome Assisted Drug Delivery Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Liposome Assisted Drug Delivery Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Liposomal Doxorubicin
Table 6. Key Players of Liposomal Amphoteracin B
Table 7. Key Players of Liposomal Paclitaxel
Table 8. Key Players of Others
Table 9. Global Liposome Assisted Drug Delivery Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Liposome Assisted Drug Delivery Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Liposome Assisted Drug Delivery Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Liposome Assisted Drug Delivery Market Share by Regions (2015-2020)
Table 13. Global Liposome Assisted Drug Delivery Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Liposome Assisted Drug Delivery Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Liposome Assisted Drug Delivery Market Growth Strategy
Table 19. Main Points Interviewed from Key Liposome Assisted Drug Delivery Players
Table 20. Global Liposome Assisted Drug Delivery Revenue by Players (2015-2020) (Million US$)
Table 21. Global Liposome Assisted Drug Delivery Market Share by Players (2015-2020)
Table 22. Global Top Liposome Assisted Drug Delivery Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Liposome Assisted Drug Delivery as of 2019)
Table 23. Global Liposome Assisted Drug Delivery by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Liposome Assisted Drug Delivery Product Solution and Service
Table 26. Date of Enter into Liposome Assisted Drug Delivery Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Liposome Assisted Drug Delivery Market Size by Type (2015-2020) (Million US$)
Table 29. Global Liposome Assisted Drug Delivery Market Size Share by Type (2015-2020)
Table 30. Global Liposome Assisted Drug Delivery Revenue Market Share by Type (2021-2026)
Table 31. Global Liposome Assisted Drug Delivery Market Size Share by Application (2015-2020)
Table 32. Global Liposome Assisted Drug Delivery Market Size by Application (2015-2020) (Million US$)
Table 33. Global Liposome Assisted Drug Delivery Market Size Share by Application (2021-2026)
Table 34. North America Key Players Liposome Assisted Drug Delivery Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Liposome Assisted Drug Delivery Market Share (2019-2020)
Table 36. North America Liposome Assisted Drug Delivery Market Size by Type (2015-2020) (Million US$)
Table 37. North America Liposome Assisted Drug Delivery Market Share by Type (2015-2020)
Table 38. North America Liposome Assisted Drug Delivery Market Size by Application (2015-2020) (Million US$)
Table 39. North America Liposome Assisted Drug Delivery Market Share by Application (2015-2020)
Table 40. Europe Key Players Liposome Assisted Drug Delivery Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Liposome Assisted Drug Delivery Market Share (2019-2020)
Table 42. Europe Liposome Assisted Drug Delivery Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Liposome Assisted Drug Delivery Market Share by Type (2015-2020)
Table 44. Europe Liposome Assisted Drug Delivery Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Liposome Assisted Drug Delivery Market Share by Application (2015-2020)
Table 46. China Key Players Liposome Assisted Drug Delivery Revenue (2019-2020) (Million US$)
Table 47. China Key Players Liposome Assisted Drug Delivery Market Share (2019-2020)
Table 48. China Liposome Assisted Drug Delivery Market Size by Type (2015-2020) (Million US$)
Table 49. China Liposome Assisted Drug Delivery Market Share by Type (2015-2020)
Table 50. China Liposome Assisted Drug Delivery Market Size by Application (2015-2020) (Million US$)
Table 51. China Liposome Assisted Drug Delivery Market Share by Application (2015-2020)
Table 52. Japan Key Players Liposome Assisted Drug Delivery Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Liposome Assisted Drug Delivery Market Share (2019-2020)
Table 54. Japan Liposome Assisted Drug Delivery Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Liposome Assisted Drug Delivery Market Share by Type (2015-2020)
Table 56. Japan Liposome Assisted Drug Delivery Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Liposome Assisted Drug Delivery Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Liposome Assisted Drug Delivery Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Liposome Assisted Drug Delivery Market Share (2019-2020)
Table 60. Southeast Asia Liposome Assisted Drug Delivery Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Liposome Assisted Drug Delivery Market Share by Type (2015-2020)
Table 62. Southeast Asia Liposome Assisted Drug Delivery Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Liposome Assisted Drug Delivery Market Share by Application (2015-2020)
Table 64. India Key Players Liposome Assisted Drug Delivery Revenue (2019-2020) (Million US$)
Table 65. India Key Players Liposome Assisted Drug Delivery Market Share (2019-2020)
Table 66. India Liposome Assisted Drug Delivery Market Size by Type (2015-2020) (Million US$)
Table 67. India Liposome Assisted Drug Delivery Market Share by Type (2015-2020)
Table 68. India Liposome Assisted Drug Delivery Market Size by Application (2015-2020) (Million US$)
Table 69. India Liposome Assisted Drug Delivery Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Liposome Assisted Drug Delivery Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Liposome Assisted Drug Delivery Market Share (2019-2020)
Table 72. Central & South America Liposome Assisted Drug Delivery Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Liposome Assisted Drug Delivery Market Share by Type (2015-2020)
Table 74. Central & South America Liposome Assisted Drug Delivery Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Liposome Assisted Drug Delivery Market Share by Application (2015-2020)
Table 76. Gilead Sciences Company Details
Table 77. Gilead Sciences Business Overview
Table 78. Gilead Sciences Product
Table 79. Gilead Sciences Revenue in Liposome Assisted Drug Delivery Business (2015-2020) (Million US$)
Table 80. Gilead Sciences Recent Development
Table 81. Pacira Company Details
Table 82. Pacira Business Overview
Table 83. Pacira Product
Table 84. Pacira Revenue in Liposome Assisted Drug Delivery Business (2015-2020) (Million US$)
Table 85. Pacira Recent Development
Table 86. Sun Pharmaceutical Company Details
Table 87. Sun Pharmaceutical Business Overview
Table 88. Sun Pharmaceutical Product
Table 89. Sun Pharmaceutical Revenue in Liposome Assisted Drug Delivery Business (2015-2020) (Million US$)
Table 90. Sun Pharmaceutical Recent Development
Table 91. Johnson & Johnson Company Details
Table 92. Johnson & Johnson Business Overview
Table 93. Johnson & Johnson Product
Table 94. Johnson & Johnson Revenue in Liposome Assisted Drug Delivery Business (2015-2020) (Million US$)
Table 95. Johnson & Johnson Recent Development
Table 96. Luye Pharma Company Details
Table 97. Luye Pharma Business Overview
Table 98. Luye Pharma Product
Table 99. Luye Pharma Revenue in Liposome Assisted Drug Delivery Business (2015-2020) (Million US$)
Table 100. Luye Pharma Recent Development
Table 101. Sigma-Tau Group Company Details
Table 102. Sigma-Tau Group Business Overview
Table 103. Sigma-Tau Group Product
Table 104. Sigma-Tau Group Revenue in Liposome Assisted Drug Delivery Business (2015-2020) (Million US$)
Table 105. Sigma-Tau Group Recent Development
Table 106. Ipsen (Onivyde) Company Details
Table 107. Ipsen (Onivyde) Business Overview
Table 108. Ipsen (Onivyde) Product
Table 109. Ipsen (Onivyde) Revenue in Liposome Assisted Drug Delivery Business (2015-2020) (Million US$)
Table 110. Ipsen (Onivyde) Recent Development
Table 111. CSPC Business Overview
Table 112. CSPC Product
Table 113. CSPC Company Details
Table 114. CSPC Revenue in Liposome Assisted Drug Delivery Business (2015-2020) (Million US$)
Table 115. CSPC Recent Development
Table 116. Teva Pharmaceutical Company Details
Table 117. Teva Pharmaceutical Business Overview
Table 118. Teva Pharmaceutical Product
Table 119. Teva Pharmaceutical Revenue in Liposome Assisted Drug Delivery Business (2015-2020) (Million US$)
Table 120. Teva Pharmaceutical Recent Development
Table 121. Novartis Company Details
Table 122. Novartis Business Overview
Table 123. Novartis Product
Table 124. Novartis Revenue in Liposome Assisted Drug Delivery Business (2015-2020) (Million US$)
Table 125. Novartis Recent Development
Table 126. Fudan-Zhangjiang Company Details
Table 127. Fudan-Zhangjiang Business Overview
Table 128. Fudan-Zhangjiang Product
Table 129. Fudan-Zhangjiang Revenue in Liposome Assisted Drug Delivery Business (2015-2020) (Million US$)
Table 130. Fudan-Zhangjiang Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
Table 1. Liposome Assisted Drug Delivery Key Market Segments
Table 2. Key Players Covered: Ranking by Liposome Assisted Drug Delivery Revenue
Table 3. Ranking of Global Top Liposome Assisted Drug Delivery Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Liposome Assisted Drug Delivery Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Liposomal Doxorubicin
Table 6. Key Players of Liposomal Amphoteracin B
Table 7. Key Players of Liposomal Paclitaxel
Table 8. Key Players of Others
Table 9. Global Liposome Assisted Drug Delivery Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Liposome Assisted Drug Delivery Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Liposome Assisted Drug Delivery Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Liposome Assisted Drug Delivery Market Share by Regions (2015-2020)
Table 13. Global Liposome Assisted Drug Delivery Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Liposome Assisted Drug Delivery Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Liposome Assisted Drug Delivery Market Growth Strategy
Table 19. Main Points Interviewed from Key Liposome Assisted Drug Delivery Players
Table 20. Global Liposome Assisted Drug Delivery Revenue by Players (2015-2020) (Million US$)
Table 21. Global Liposome Assisted Drug Delivery Market Share by Players (2015-2020)
Table 22. Global Top Liposome Assisted Drug Delivery Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Liposome Assisted Drug Delivery as of 2019)
Table 23. Global Liposome Assisted Drug Delivery by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Liposome Assisted Drug Delivery Product Solution and Service
Table 26. Date of Enter into Liposome Assisted Drug Delivery Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Liposome Assisted Drug Delivery Market Size by Type (2015-2020) (Million US$)
Table 29. Global Liposome Assisted Drug Delivery Market Size Share by Type (2015-2020)
Table 30. Global Liposome Assisted Drug Delivery Revenue Market Share by Type (2021-2026)
Table 31. Global Liposome Assisted Drug Delivery Market Size Share by Application (2015-2020)
Table 32. Global Liposome Assisted Drug Delivery Market Size by Application (2015-2020) (Million US$)
Table 33. Global Liposome Assisted Drug Delivery Market Size Share by Application (2021-2026)
Table 34. North America Key Players Liposome Assisted Drug Delivery Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Liposome Assisted Drug Delivery Market Share (2019-2020)
Table 36. North America Liposome Assisted Drug Delivery Market Size by Type (2015-2020) (Million US$)
Table 37. North America Liposome Assisted Drug Delivery Market Share by Type (2015-2020)
Table 38. North America Liposome Assisted Drug Delivery Market Size by Application (2015-2020) (Million US$)
Table 39. North America Liposome Assisted Drug Delivery Market Share by Application (2015-2020)
Table 40. Europe Key Players Liposome Assisted Drug Delivery Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Liposome Assisted Drug Delivery Market Share (2019-2020)
Table 42. Europe Liposome Assisted Drug Delivery Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Liposome Assisted Drug Delivery Market Share by Type (2015-2020)
Table 44. Europe Liposome Assisted Drug Delivery Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Liposome Assisted Drug Delivery Market Share by Application (2015-2020)
Table 46. China Key Players Liposome Assisted Drug Delivery Revenue (2019-2020) (Million US$)
Table 47. China Key Players Liposome Assisted Drug Delivery Market Share (2019-2020)
Table 48. China Liposome Assisted Drug Delivery Market Size by Type (2015-2020) (Million US$)
Table 49. China Liposome Assisted Drug Delivery Market Share by Type (2015-2020)
Table 50. China Liposome Assisted Drug Delivery Market Size by Application (2015-2020) (Million US$)
Table 51. China Liposome Assisted Drug Delivery Market Share by Application (2015-2020)
Table 52. Japan Key Players Liposome Assisted Drug Delivery Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Liposome Assisted Drug Delivery Market Share (2019-2020)
Table 54. Japan Liposome Assisted Drug Delivery Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Liposome Assisted Drug Delivery Market Share by Type (2015-2020)
Table 56. Japan Liposome Assisted Drug Delivery Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Liposome Assisted Drug Delivery Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Liposome Assisted Drug Delivery Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Liposome Assisted Drug Delivery Market Share (2019-2020)
Table 60. Southeast Asia Liposome Assisted Drug Delivery Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Liposome Assisted Drug Delivery Market Share by Type (2015-2020)
Table 62. Southeast Asia Liposome Assisted Drug Delivery Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Liposome Assisted Drug Delivery Market Share by Application (2015-2020)
Table 64. India Key Players Liposome Assisted Drug Delivery Revenue (2019-2020) (Million US$)
Table 65. India Key Players Liposome Assisted Drug Delivery Market Share (2019-2020)
Table 66. India Liposome Assisted Drug Delivery Market Size by Type (2015-2020) (Million US$)
Table 67. India Liposome Assisted Drug Delivery Market Share by Type (2015-2020)
Table 68. India Liposome Assisted Drug Delivery Market Size by Application (2015-2020) (Million US$)
Table 69. India Liposome Assisted Drug Delivery Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Liposome Assisted Drug Delivery Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Liposome Assisted Drug Delivery Market Share (2019-2020)
Table 72. Central & South America Liposome Assisted Drug Delivery Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Liposome Assisted Drug Delivery Market Share by Type (2015-2020)
Table 74. Central & South America Liposome Assisted Drug Delivery Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Liposome Assisted Drug Delivery Market Share by Application (2015-2020)
Table 76. Gilead Sciences Company Details
Table 77. Gilead Sciences Business Overview
Table 78. Gilead Sciences Product
Table 79. Gilead Sciences Revenue in Liposome Assisted Drug Delivery Business (2015-2020) (Million US$)
Table 80. Gilead Sciences Recent Development
Table 81. Pacira Company Details
Table 82. Pacira Business Overview
Table 83. Pacira Product
Table 84. Pacira Revenue in Liposome Assisted Drug Delivery Business (2015-2020) (Million US$)
Table 85. Pacira Recent Development
Table 86. Sun Pharmaceutical Company Details
Table 87. Sun Pharmaceutical Business Overview
Table 88. Sun Pharmaceutical Product
Table 89. Sun Pharmaceutical Revenue in Liposome Assisted Drug Delivery Business (2015-2020) (Million US$)
Table 90. Sun Pharmaceutical Recent Development
Table 91. Johnson & Johnson Company Details
Table 92. Johnson & Johnson Business Overview
Table 93. Johnson & Johnson Product
Table 94. Johnson & Johnson Revenue in Liposome Assisted Drug Delivery Business (2015-2020) (Million US$)
Table 95. Johnson & Johnson Recent Development
Table 96. Luye Pharma Company Details
Table 97. Luye Pharma Business Overview
Table 98. Luye Pharma Product
Table 99. Luye Pharma Revenue in Liposome Assisted Drug Delivery Business (2015-2020) (Million US$)
Table 100. Luye Pharma Recent Development
Table 101. Sigma-Tau Group Company Details
Table 102. Sigma-Tau Group Business Overview
Table 103. Sigma-Tau Group Product
Table 104. Sigma-Tau Group Revenue in Liposome Assisted Drug Delivery Business (2015-2020) (Million US$)
Table 105. Sigma-Tau Group Recent Development
Table 106. Ipsen (Onivyde) Company Details
Table 107. Ipsen (Onivyde) Business Overview
Table 108. Ipsen (Onivyde) Product
Table 109. Ipsen (Onivyde) Revenue in Liposome Assisted Drug Delivery Business (2015-2020) (Million US$)
Table 110. Ipsen (Onivyde) Recent Development
Table 111. CSPC Business Overview
Table 112. CSPC Product
Table 113. CSPC Company Details
Table 114. CSPC Revenue in Liposome Assisted Drug Delivery Business (2015-2020) (Million US$)
Table 115. CSPC Recent Development
Table 116. Teva Pharmaceutical Company Details
Table 117. Teva Pharmaceutical Business Overview
Table 118. Teva Pharmaceutical Product
Table 119. Teva Pharmaceutical Revenue in Liposome Assisted Drug Delivery Business (2015-2020) (Million US$)
Table 120. Teva Pharmaceutical Recent Development
Table 121. Novartis Company Details
Table 122. Novartis Business Overview
Table 123. Novartis Product
Table 124. Novartis Revenue in Liposome Assisted Drug Delivery Business (2015-2020) (Million US$)
Table 125. Novartis Recent Development
Table 126. Fudan-Zhangjiang Company Details
Table 127. Fudan-Zhangjiang Business Overview
Table 128. Fudan-Zhangjiang Product
Table 129. Fudan-Zhangjiang Revenue in Liposome Assisted Drug Delivery Business (2015-2020) (Million US$)
Table 130. Fudan-Zhangjiang Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Liposome Assisted Drug Delivery Market Share by Type: 2020 VS 2026
Figure 2. Liposomal Doxorubicin Features
Figure 3. Liposomal Amphoteracin B Features
Figure 4. Liposomal Paclitaxel Features
Figure 5. Others Features
Figure 6. Global Liposome Assisted Drug Delivery Market Share by Application: 2020 VS 2026
Figure 7. Fungal Infection Therapy Case Studies
Figure 8. Cancer & Tumor Therapy Case Studies
Figure 9. Others Case Studies
Figure 10. Liposome Assisted Drug Delivery Report Years Considered
Figure 11. Global Liposome Assisted Drug Delivery Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Liposome Assisted Drug Delivery Market Share by Regions: 2020 VS 2026
Figure 13. Global Liposome Assisted Drug Delivery Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Liposome Assisted Drug Delivery Market Share by Players in 2019
Figure 16. Global Top Liposome Assisted Drug Delivery Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Liposome Assisted Drug Delivery as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Liposome Assisted Drug Delivery Revenue in 2019
Figure 18. North America Liposome Assisted Drug Delivery Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Liposome Assisted Drug Delivery Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Liposome Assisted Drug Delivery Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Liposome Assisted Drug Delivery Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Liposome Assisted Drug Delivery Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Liposome Assisted Drug Delivery Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Liposome Assisted Drug Delivery Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed
Figure 1. Global Liposome Assisted Drug Delivery Market Share by Type: 2020 VS 2026
Figure 2. Liposomal Doxorubicin Features
Figure 3. Liposomal Amphoteracin B Features
Figure 4. Liposomal Paclitaxel Features
Figure 5. Others Features
Figure 6. Global Liposome Assisted Drug Delivery Market Share by Application: 2020 VS 2026
Figure 7. Fungal Infection Therapy Case Studies
Figure 8. Cancer & Tumor Therapy Case Studies
Figure 9. Others Case Studies
Figure 10. Liposome Assisted Drug Delivery Report Years Considered
Figure 11. Global Liposome Assisted Drug Delivery Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Liposome Assisted Drug Delivery Market Share by Regions: 2020 VS 2026
Figure 13. Global Liposome Assisted Drug Delivery Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Liposome Assisted Drug Delivery Market Share by Players in 2019
Figure 16. Global Top Liposome Assisted Drug Delivery Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Liposome Assisted Drug Delivery as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Liposome Assisted Drug Delivery Revenue in 2019
Figure 18. North America Liposome Assisted Drug Delivery Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Liposome Assisted Drug Delivery Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Liposome Assisted Drug Delivery Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Liposome Assisted Drug Delivery Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Liposome Assisted Drug Delivery Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Liposome Assisted Drug Delivery Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Liposome Assisted Drug Delivery Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed